Log in to your Inderes Free account to see all free content on this page.

Hofseth BioCare

Less than 1K followers

HBC

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

Overview

Ownership

Investor consensus

Hofseth BioCare is a Norwegian company active in biotechnology. The company develops various protein and calcium powders, as well as salmon oil. By using patented technology, the company can extract substances for production at an early stage. The products are delivered in the form of dietary supplements and sold through health stores. The company was founded in 2009 and has its headquarters in Ålesund.

Market cap

-

Turnover

-

Revenue

EBIT %

P/E

Dividend yield-%

Financial calendar

13.2.

2026

Annual report '25

8.5.

2026

Interim report Q1'26

22.5.

2026

General meeting '26

All

Press releases

ShowingAll content types

Regulatory press release12/3/2025, 12:44 PM

HBC: Financial calendar

Hofseth BioCare

Regulatory press release11/21/2025, 9:28 AM

Hofseth BioCare ASA: PRIMARY INSIDER NOTIFICATION

Hofseth BioCare

Regulatory press release11/21/2025, 9:14 AM

Hofseth BioCare ASA: RESULTS OF SUBSEQUENT OFFERING

Hofseth BioCare

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release11/20/2025, 10:30 AM

Hofseth BioCare ASA: Extraordinary General Meeting completed

Hofseth BioCare

Regulatory press release11/20/2025, 8:11 AM

Hofseth BioCare ASA: LAST DAY OF SUBSCRIPTION PERIOD IN SUBSEQUENT OFFERING

Hofseth BioCare

Regulatory press release11/20/2025, 7:58 AM

Hofseth BioCare ASA: HBC ANNOUNCES STRATEGIC PRODUCT PARTNERSHIP WITH JAMES LAVALLE & METABOLIC ELITE

Hofseth BioCare

Regulatory press release11/20/2025, 7:58 AM

Hofseth BioCare ASA: HBC ANNOUNCES STRATEGIC PRODUCT PARTNERSHIP WITH JAMES LAVALLE & METABOLIC ELITE

Hofseth BioCare

Regulatory press release11/10/2025, 7:33 AM

Hofseth BioCare ASA: Publication of the Prospectus – Start of the Subscription Period for the Subsequent Offering

Hofseth BioCare

Regulatory press release11/7/2025, 7:55 AM

Hofseth BioCare ASA: Terms of the Subsequent Offering

Hofseth BioCare

Regulatory press release11/7/2025, 7:00 AM

Hofseth BioCare ASA: THIRD QUARTER 2025 FINANCIAL REPORT

Hofseth BioCare

Regulatory press release10/30/2025, 7:36 AM

Hofseth BioCare ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING

Hofseth BioCare

Regulatory press release10/27/2025, 9:56 AM

Hofseth BioCare ASA: Mandatory Notification of Trade

Hofseth BioCare

Regulatory press release10/27/2025, 7:03 AM

HBC: Ex. Subsequent Offering Today

Hofseth BioCare

Regulatory press release10/27/2025, 7:03 AM

Ex. Subsequent Offering Today

Hofseth BioCare

Regulatory press release10/27/2025, 7:02 AM

Hofseth BioCare ASA: Key Information Relating to Subsequent Offering

Hofseth BioCare

Regulatory press release10/27/2025, 7:01 AM

Hofseth BioCare ASA: Disclosures of Large Shareholdings

Hofseth BioCare

Regulatory press release10/27/2025, 7:01 AM

Hofseth BioCare ASA: Disclosures of Large Shareholdings

Hofseth BioCare

Regulatory press release10/27/2025, 7:00 AM

Hofseth BioCare ASA: Private placement successfully placed

Hofseth BioCare

Regulatory press release10/24/2025, 3:56 PM

Hofseth Biocare ASA: USD 5 Million Divestment in Aecorbio

Hofseth BioCare

Regulatory press release10/24/2025, 3:48 PM

Hofseth BioCare ASA: Contemplated Private Placement and Partial Divestment of Shares in Aecorbio

Hofseth BioCare

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.